Acadian Asset Management’s Treace Medical Concepts TMCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.69M Sell
928,177
-13,116
-1% -$36.1K ﹤0.01% 893
2026
Q1
$1.25M Buy
941,293
+278,508
+42% +$555K ﹤0.01% 1091
2025
Q4
$1.62M Buy
662,785
+390,848
+144% +$1.7M ﹤0.01% 972
2025
Q3
$1.82M Buy
271,937
+130,212
+92% +$850K ﹤0.01% 914
2025
Q2
$832K Buy
141,725
+15,268
+12% +$99.5K ﹤0.01% 1015
2025
Q1
$1.06M Buy
126,457
+50,669
+67% +$455K ﹤0.01% 922
2024
Q4
$563K Sell
75,788
-48,456
-39% -$324K ﹤0.01% 1050
2024
Q3
$718K Sell
124,244
-213,975
-63% -$1.37M ﹤0.01% 996
2024
Q2
$2.25M Buy
+338,219
New +$2.73M 0.01% 729

Other funds holding TMCI

Acadian Asset Management's TMCI Position: Q2 2026 in Review

Acadian Asset Management reduced its Treace Medical Concepts (TMCI) stake by 1.4% in Q2 2026, selling an estimated $36.1K and leaving 928,177 shares worth $3.69M. The position accounts for ﹤0.01% of the portfolio, ranked #893.

Acadian Asset Management first reported a position in TMCI in Q2 2024 and has held it in 9 quarters since. 117 funds tracked by Wall St. Rank hold TMCI as of Q2 2026.

  • Acadian Asset Management held 928,177 shares of Treace Medical Concepts worth $3.69M as of Q2 2026.
  • Acadian Asset Management sold 13,116 Treace Medical Concepts shares in Q2 2026, an estimated $36.1K.
  • Treace Medical Concepts made up ﹤0.01% of Acadian Asset Management's portfolio in Q2 2026, its #893 holding.
  • Acadian Asset Management first reported a position in Treace Medical Concepts in Q2 2024 and has held it in 9 quarters since.
  • 117 funds tracked by Wall St. Rank held Treace Medical Concepts as of Q2 2026.

Based on Acadian Asset Management's 13F filing for Q2 2026, filed 13 Aug 2026.